Sophiris Bio Inc. (NASDAQ:SPHS) a biopharmaceutical company developing a clinical stage, targeted treatment for the symptoms of benign prostatic hyperplasia (BPH) or enlarged prostate announced that Randall E. Woods, president and chief executive officer, will present a corporate overview at the 13th Annual Needham Healthcare Conference. The presentation is scheduled for Tuesday, April 8th at 3:00 p.m. EDT at the Westin Grand Central Hotel in New York, New York. Sophiris Bio Inc. (NASDAQ:SPHS) shares advanced 0.90% in last trading session and ended the day on $3.38. SPHS return on equity ratio is recorded as -157.70% and its return on assets is -50.90%. Sophiris Bio Inc. (NASDAQ:SPHS) yearly performance is -70.45%.
Nature’s Sunshine Products, Inc. (NASDAQ:NATR) begin trading ex-dividend on March 26, 2014. A cash dividend payment of $0.1 per share is scheduled to be paid on April 07, 2014. Nature’s Sunshine Prod. (NASDAQ:NATR) shares moved up 0.72% in last trading session and was closed at $14.00, while trading in range of $13.88 – $14.13. Nature’s Sunshine Prod. (NASDAQ:NATR) year to date (YTD) performance is -17.98%.
On March 25, 2014, Evoke Pharma, Inc. (NASDAQ:EVOK) issued a press release announcing its financial results for the quarter and full year ended December 31, 2013. Evoke Pharma Inc. (NASDAQ:EVOK) weekly performance is -12.96%. On last trading day company shares ended up $9.00. Evoke Pharma Inc. (NASDAQ:EVOK) distance from 50-day simple moving average (SMA50) is -11.86%. Analysts mean target price for the company is $32.33.
Myrexis Inc. (OTCMKTS:MYRX) shares after opening at $0.16 moved to $0.17 on last trade day and at the end of the day closed at $0.170. Company price to sales ratio in past twelve months was calculated as – and price to cash ratio as 0.05.